演讲题目
药物开发新时代中的项目管理和运营模式

孙壮

Dr John Sun is a Global Program Lead at Novartis, and had served as Global Analytics Project Manager and Global Program Team Director in different franchises and units. Before Novartis, John held positions with increased R&D responsibilities from Whitehall-Robins, Kos Pharmaceuticals, Schering-Plough, and Sanofi-Aventis. Over the years, John has actively volunteered in various professional organizations, served as Chair of Project Management Community in DIA, SAPA Executive Council and Career Lead, Chair of Chinese Culture Community, President of Novartis Toastmasters Club and Area Director of Toastmasters International at District 83. John had presented in various domestic and international symposia on PM and drug development. John obtained his PhD in pharmaceutics from Virginia Commonwealth University, MBA from Rutgers University, and BMed from Beijing University of Traditional Chinese Medicine. John is a certified Project Management Professional (PMP) and trained in black-belt for lean six-sigma.

Dr John Sun is a Global Program Lead at Novartis, and had served as Global Analytics Project Manager and Global Program Team Director in different franchises and units. Before Novartis, John held positions with increased R&D responsibilities from Whitehall-Robins, Kos Pharmaceuticals, Schering-Plough, and Sanofi-Aventis. Over the years, John has actively volunteered in various professional organizations, served as Chair of Project Management Community in DIA, SAPA Executive Council and Career Lead, Chair of Chinese Culture Community, President of Novartis Toastmasters Club and Area Director of Toastmasters International at District 83. John had presented in various domestic and international symposia on PM and drug development. John obtained his PhD in pharmaceutics from Virginia Commonwealth University, MBA from Rutgers University, and BMed from Beijing University of Traditional Chinese Medicine. John is a certified Project Management Professional (PMP) and trained in black-belt for lean six-sigma.